Cargando…

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients

In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz de Porras, Vicenç, Bystrup, Sara, Cabrero-de las Heras, Sara, Musulén, Eva, Palomero, Luis, Alonso, Maria Henar, Nieto, Rocio, Arango, Diego, Moreno, Víctor, Queralt, Cristina, Manzano, José Luis, Layos, Laura, Bugés, Cristina, Martinez-Balibrea, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826373/ https://www.ncbi.nlm.nih.gov/pubmed/31614664 http://dx.doi.org/10.3390/cancers11101540

Ejemplares similares

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
por: Ginés, Alba, et al.
Publicado: (2015)

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2016)

Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
por: Layos, Laura, et al.
Publicado: (2022)

CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
por: Cabrero-de las Heras, Sara, et al.
Publicado: (2018)

Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents
por: Antelo, Gabriela, et al.
Publicado: (2020)

HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies
por: Pous, Anna, et al.
Publicado: (2023)

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
por: Moutinho, Catia, et al.
Publicado: (2013)

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
por: Bernat-Peguera, Adrià, et al.
Publicado: (2022)

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

Aquaporin‐5 in breast cancer
por: Bystrup, Malte, et al.
Publicado: (2022)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Cyclin-dependent kinase 5 (CDK5) regulates the circadian clock
por: Brenna, Andrea, et al.
Publicado: (2019)

Mutational Pattern Induced by 5-Fluorouracil and Oxaliplatin in the Gut Microbiome
por: Wan, Li, et al.
Publicado: (2022)

Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation
por: Liu, Chengcheng, et al.
Publicado: (2017)

Erratum: Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation
por: Liu, Chengcheng, et al.
Publicado: (2017)

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer
por: Gravalos, Cristina, et al.
Publicado: (2012)

The Transcription Factor NFAT5 Is Required for Cyclin Expression and Cell Cycle Progression in Cells Exposed to Hypertonic Stress
por: Drews-Elger, Katherine, et al.
Publicado: (2009)

A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
por: Papadia, Paride, et al.
Publicado: (2019)

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin
por: Cui, Wei, et al.
Publicado: (2017)

Regulation of Hippocampal and Behavioral Excitability by Cyclin-Dependent Kinase 5
por: Hawasli, Ammar H., et al.
Publicado: (2009)

Regulation of Sox6 by Cyclin Dependent Kinase 5 in Brain
por: Rudrabhatla, Parvathi, et al.
Publicado: (2014)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022)

Cyclin C: The Story of a Non-Cycling Cyclin
por: Ježek, Jan, et al.
Publicado: (2019)

Towards an Integrated Care Organisation from a CEO Perspective
por: Amunarriz, Gerardo, et al.
Publicado: (2020)

Atypical cyclins: the extended family portrait
por: Quandt, Eva, et al.
Publicado: (2019)

Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
por: Buchler, Tomas, et al.
Publicado: (2014)

Regulation of Neuronal Ca(v)3.1 Channels by Cyclin-Dependent Kinase 5 (Cdk5)
por: Calderón-Rivera, Aida, et al.
Publicado: (2015)

Activation of Cyclin-Dependent Kinase 5 Is a Consequence of Cell Death
por: Ye, Yixia, et al.
Publicado: (2009)

Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
por: Prochazkova, Michaela, et al.
Publicado: (2013)

Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy
por: Dixit, Aparna Banerjee, et al.
Publicado: (2017)

Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
por: Katayama, Syouichi, et al.
Publicado: (2020)

RECURRENT SELF-LIMITED HYPERTHERMIA FOLLOWING ELECTROCONVULSIVE THERAPY
por: Eva María, Sánchez-Morla, et al.
Publicado: (2023)

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer
por: Zhang, Sheng, et al.
Publicado: (2016)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?
por: Municio, Cristina, et al.
Publicado: (2022)

Cdk5-mediated Phosphorylation of c-Myc on Ser-62 Is Essential in Transcriptional Activation of Cyclin B1 by Cyclin G1
por: Seo, Haeng Ran, et al.
Publicado: (2008)

The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals
por: Carrato, Cristina, et al.
Publicado: (2021)

Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_os7ftl67clfqdfiqs7eg0npq1l